Published in BMJ on July 28, 2011
Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet (2012) 6.81
The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43
Improvements in US Breast Cancer Survival and Proportion Explained by Tumor Size and Estrogen-Receptor Status. J Clin Oncol (2015) 3.19
Modern mammography screening and breast cancer mortality: population study. BMJ (2014) 1.92
Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program. Breast Cancer Res Treat (2012) 1.47
Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study. Br J Cancer (2013) 1.42
Citations of scientific results and conflicts of interest: the case of mammography screening. Evid Based Med (2013) 1.42
Benefits and harms of mammography screening. Breast Cancer Res (2015) 1.22
Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase? Br J Cancer (2011) 1.16
Challenges to the early diagnosis and treatment of breast cancer in developing countries. World J Clin Oncol (2014) 1.09
Breast cancer screening: evidence of benefit depends on the method used. BMC Med (2012) 1.04
Breast cancer screening: are we seeing the benefit? BMC Med (2012) 1.02
Time to stop mammography screening? CMAJ (2011) 1.02
Breast cancer screening: the questions answered. Nat Rev Clin Oncol (2012) 1.02
Arguments against mammography screening continue to be based on faulty science. Oncologist (2014) 1.00
An investigation of the apparent breast cancer epidemic in France: screening and incidence trends in birth cohorts. BMC Cancer (2011) 0.99
Beyond the mammography debate: a moderate perspective. Curr Oncol (2015) 0.97
Effects of age on the detection and management of breast cancer. Cancers (Basel) (2015) 0.94
Breast cancer in European Union: an update of screening programmes as of March 2014 (review). Int J Oncol (2014) 0.88
An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients. Ecancermedicalscience (2016) 0.88
Were our estimates of overdiagnosis with mammography screening in the United States "based on faulty science"? Oncologist (2014) 0.87
Challenges in Biomarker Discovery: Combining Expert Insights with Statistical Analysis of Complex Omics Data. Expert Opin Med Diagn (2013) 0.86
Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer. Int J Clin Exp Pathol (2015) 0.86
US breast cancer mortality is consistent with European data. BMJ (2011) 0.84
Epithelial cell dissemination and readhesion: analysis of factors contributing to metastasis formation in breast cancer. ISRN Oncol (2012) 0.83
Screening: part 19 of a series on evaluation of scientific publications. Dtsch Arztebl Int (2012) 0.83
Population-based service mammography screening: the Icelandic experience. Breast Cancer (Dove Med Press) (2013) 0.81
The apoptotic effects of sirtuin1 inhibitor on the MCF-7 and MRC-5 cell lines. Res Pharm Sci (2013) 0.80
Marginal public health gain of screening for colorectal cancer: modelling study, based on WHO and national databases in the Nordic countries. J Eval Clin Pract (2012) 0.80
Is the tide turning against breast screening? Breast Cancer Res (2012) 0.80
Four Principles to Consider Before Advising Women on Screening Mammography. J Womens Health (Larchmt) (2015) 0.79
Effect of Thymoquinone on P53 Gene Expression and Consequence Apoptosis in Breast Cancer Cell Line. Int J Prev Med (2016) 0.79
The effect of CTB on P53 protein acetylation and consequence apoptosis on MCF-7 and MRC-5 cell lines. Adv Biomed Res (2013) 0.79
RELATIVE EFFECTIVENESS IN BREAST CANCER TREATMENT: A HEALTH PRODUCTION APPROACH. Int J Technol Assess Health Care (2016) 0.79
Breast cancer causes and treatment: where are we going wrong? Breast Cancer (Dove Med Press) (2013) 0.78
Mammography screening in three Finnish residential areas: comprehensive population-based study of breast cancer incidence and incidence-based mortality 1976-2009. Br J Cancer (2015) 0.77
Physical activity and the risk of postmenopausal breast cancer - the Norwegian Women and Cancer Study. J Negat Results Biomed (2014) 0.77
Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK. Breast (2015) 0.77
The impact of the Polish mass breast cancer screening program on prognosis in the Pomeranian Province. Arch Med Sci (2016) 0.77
Women's participation in breast cancer screening in France--an ethical approach. BMC Med Ethics (2014) 0.77
An abnormal screening mammogram causes more anxiety than a palpable lump in benign breast disease. Breast Cancer Res Treat (2012) 0.77
Breast and prostate cancer: an analysis of common epidemiological features in mortality trends in Spain. BMC Cancer (2014) 0.76
Breast cancer in Wales: time trends and geographical distribution. Gland Surg (2014) 0.76
Breast screening review--a radiologist's perspective. Br J Radiol (2012) 0.76
Combination of Salermide and Cholera Toxin B Induce Apoptosis in MCF-7 but Not in MRC-5 Cell Lines. Int J Prev Med (2013) 0.76
The pitfall of the transient, inconsistent anticancer capacity of antiestrogens and the mechanism of apparent antiestrogen resistance. Drug Des Devel Ther (2015) 0.76
Mammographic screening for breast cancer: A review. J Med Radiat Sci (2013) 0.75
Trend Analysis of Cancer Mortality and Incidence in Panama, Using Joinpoint Regression Analysis. Medicine (Baltimore) (2015) 0.75
New analysis reexamines the value of cancer care in the United States compared to Western Europe. Health Aff (Millwood) (2015) 0.75
Observed and Predicted Risk of Breast Cancer Death in Randomized Trials on Breast Cancer Screening. PLoS One (2016) 0.75
Provision of breast cancer care and survival in Germany - results from a population-based high resolution study from Saarland. BMC Cancer (2014) 0.75
Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program. Cancer (2015) 0.75
Viewpoint: It is time to reconsider policy for population-based mammography screening. J Public Health Policy (2015) 0.75
Screening: Reduced breast cancer mortality rates in Europe are not due to screening. Nat Rev Clin Oncol (2011) 0.75
Incidence and Mortality Trends in German Women with Breast Cancer Using Age, Period and Cohort 1999 to 2008. PLoS One (2016) 0.75
Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey. BMC Cancer (2016) 0.75
Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry. Breast Cancer Res Treat (2016) 0.75
The global challenge of reducing breast cancer mortality. Oncologist (2013) 0.75
Justification of CT for Individual Health Assessment of Asymptomatic Persons: A World Health Organization Consultation. J Am Coll Radiol (2016) 0.75
The Roles of the Learned Societies in Improving Quality of Life in the context of Globalisation. Ann Med Surg (Lond) (2012) 0.75
Do not jump too quickly to conclusions. Breast Cancer Res (2012) 0.75
Decision aid on breast cancer screening reduces attendance rate: results of a large-scale, randomized, controlled study by the DECIDEO group. Oncotarget (2016) 0.75
Racial disparities in survival and age-related outcome in postsurgery breast cancer patients in a new york city community hospital. ISRN Oncol (2014) 0.75
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med (2005) 16.70
Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ (2005) 15.50
Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet (2002) 13.16
Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ (1988) 9.71
Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med (2010) 8.71
Rethinking screening for breast cancer and prostate cancer. JAMA (2009) 7.83
Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ (2010) 7.00
Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet (1987) 6.91
Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. Early Breast Cancer Trialists' Collaborative Group. N Engl J Med (1988) 4.68
Mammographic screening: no reliable supporting evidence? Lancet (2002) 4.03
Risk factors for the incidence of breast cancer: do they affect survival from the disease? J Clin Oncol (2008) 3.73
Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ (2010) 2.99
Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev (2006) 2.53
Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program. Eur J Epidemiol (2007) 1.89
Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer (2004) 1.85
Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer (2009) 1.80
Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden. PLoS Med (2006) 1.79
Treatment of breast cancer in older women. Acta Oncol (2008) 1.74
Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. J Clin Oncol (2009) 1.71
Hospital admissions for acute myocardial infarction, angina, stroke, and asthma after implementation of Arizona's comprehensive statewide smoking ban. Am J Public Health (2010) 1.67
Advanced breast cancer incidence following population-based mammographic screening. Ann Oncol (2011) 1.53
Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol (2008) 1.38
A global comparison regarding patient access to cancer drugs. Ann Oncol (2007) 1.16
Implementation of service screening with mammography in Sweden: from pilot study to nationwide programme. J Med Screen (2000) 1.07
Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975-2006. Int J Cancer (2008) 1.07
Attitude or access: reasons for not attending mammography in Northern Ireland. Eur J Cancer Prev (1992) 1.03
Prevalence of main cancer lifestyle risk factors in Europe in 2000. Eur J Cancer (2010) 1.01
The influence of aging on the early detection, diagnosis, and treatment of breast cancer. Curr Oncol Rep (2005) 1.00
Reduction in mortality from breast cancer. BMJ (2005) 0.99
Diverging breast cancer mortality rates in relation to screening? A comparison of Nijmegen to Arnhem and the Netherlands, 1969-1997. Int J Cancer (2001) 0.92
Breast cancer screening programmes--results of studies in foreign countries--situation in Belgium. Eur J Cancer Prev (1993) 0.86
Mammography screening. J Natl Cancer Inst (1995) 0.84
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ (2010) 7.00
Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet (2009) 3.76
Radiotherapy capacity in European countries: an analysis of the Directory of Radiotherapy Centres (DIRAC) database. Lancet Oncol (2013) 2.91
Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007. Acta Oncol (2013) 2.84
Balancing the harms and benefits of early detection of prostate cancer. Cancer (2010) 2.71
Tobacco smoking and cancer: a meta-analysis. Int J Cancer (2008) 2.64
Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality. BJU Int (2008) 2.60
Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet Gynecol (2009) 2.56
Insomnia and the risk of acute myocardial infarction: a population study. Circulation (2011) 2.54
Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer (2011) 2.43
Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study. Lancet (2008) 2.38
Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007. Thorax (2013) 2.19
Causes of death among Belgian professional military radar operators: a 37-year retrospective cohort study. Int J Cancer (2009) 2.17
Pitfalls in using case-control studies for the evaluation of the effectiveness of breast screening programmes. Eur J Cancer Prev (2013) 2.04
Blood pressure in early adolescence in the offspring of preeclamptic and normotensive pregnancies. J Hypertens (2009) 1.97
Temporal changes in resting heart rate and deaths from ischemic heart disease. JAMA (2011) 1.94
Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer (2009) 1.90
Tobacco smoking and thyroid function: a population-based study. Arch Intern Med (2007) 1.89
Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study. Arch Intern Med (2008) 1.88
Methods of calculating prostate-specific antigen velocity. Eur Urol (2006) 1.84
Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb. J Thorac Oncol (2008) 1.74
Estimates of the cancer burden in Europe from radioactive fallout from the Chernobyl accident. Int J Cancer (2006) 1.71
Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. J Clin Oncol (2009) 1.71
Attributable fraction of tobacco smoking on cancer using population-based nationwide cancer incidence and mortality data in Korea. BMC Cancer (2014) 1.71
A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur J Cancer (2005) 1.70
Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ (2005) 1.70
Segmental and global longitudinal strain and strain rate based on echocardiography of 1266 healthy individuals: the HUNT study in Norway. Eur J Echocardiogr (2009) 1.69
Birthweight and mortality in adulthood: a systematic review and meta-analysis. Int J Epidemiol (2011) 1.67
Glycaemic control in newly diagnosed diabetes patients and mortality from ischaemic heart disease: 20-year follow-up of the HUNT Study in Norway. Eur Heart J (2009) 1.64
Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation (2010) 1.62
The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol (2007) 1.62
Risk of adenocarcinoma in Barrett's oesophagus: population based study. BMJ (2003) 1.61
Recent trends and patterns in breast cancer incidence among Eastern and Southeastern Asian women. Cancer Causes Control (2010) 1.61
Associations of prepregnancy cardiovascular risk factors with the offspring's birth weight. Am J Epidemiol (2007) 1.59
Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study. BMJ (2009) 1.59
Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Eur J Epidemiol (2013) 1.55
Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study. BMJ (2008) 1.54
Estimating the number of alcohol-attributable deaths: methodological issues and illustration with French data for 2006. Addiction (2010) 1.51
Breast cancer tumor growth estimated through mammography screening data. Breast Cancer Res (2008) 1.43
Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Am J Clin Nutr (2013) 1.42
Pubertal development in daughters of women with pre-eclampsia. Arch Dis Child (2010) 1.41
Prostate cancer mortality in screen and clinically detected prostate cancer: estimating the screening benefit. Eur J Cancer (2009) 1.41
[Unnecessary cervical smears in young women?]. Tidsskr Nor Laegeforen (2007) 1.39
Increased risk of placenta previa in pregnancies following IVF/ICSI; a comparison of ART and non-ART pregnancies in the same mother. Hum Reprod (2006) 1.37
Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study. J Clin Endocrinol Metab (2007) 1.36
Caution needed for country-specific cancer survival. Lancet (2011) 1.34
Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes Control (2003) 1.32
Reference values and distribution of conventional echocardiographic Doppler measures and longitudinal tissue Doppler velocities in a population free from cardiovascular disease. Circ Cardiovasc Imaging (2010) 1.31
Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results. J Med Screen (2005) 1.29
Secular trends in breast cancer mortality in five East Asian populations: Hong Kong, Japan, Korea, Singapore and Taiwan. Cancer Sci (2010) 1.21
Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. Hum Mol Genet (2011) 1.17
Association of serum TSH with high body mass differs between smokers and never-smokers. J Clin Endocrinol Metab (2009) 1.17
Sunscreen use and increased duration of intentional sun exposure: still a burning issue. Int J Cancer (2007) 1.16
Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. Eur J Cancer (2009) 1.15
A melanoma epidemic in Iceland: possible influence of sunbed use. Am J Epidemiol (2010) 1.15
Recreational physical activity and risk of prostate cancer: A prospective population-based study in Norway (the HUNT study). Int J Cancer (2006) 1.11
Association of thyroid function with estimated glomerular filtration rate in a population-based study: the HUNT study. Eur J Endocrinol (2010) 1.10
RE: Relationship between sunbed use and melanoma risk in a large case-control study in the United Kingdom. Int J Cancer (2012) 1.09
Thyroid function and cancer risk: a prospective population study. Cancer Epidemiol Biomarkers Prev (2009) 1.07
Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening. J Med Screen (2008) 1.05
Birth size in relation to age at menarche and adolescent body size: implications for breast cancer risk. Int J Cancer (2003) 1.05
Placental weight relative to birth weight and long-term cardiovascular mortality: findings from a cohort of 31,307 men and women. Am J Epidemiol (2009) 1.04
Breast cancer screening: evidence of benefit depends on the method used. BMC Med (2012) 1.04
Reviews on sun exposure and artificial light and melanoma. Prog Biophys Mol Biol (2011) 1.02
Cardiovascular risk factors prior to conception and the length of pregnancy: population-based cohort study. Am J Obstet Gynecol (2011) 1.02
Cancer survival statistics should be viewed with caution. Lancet Oncol (2007) 1.02
Breast cancer screening: the questions answered. Nat Rev Clin Oncol (2012) 1.02
Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study. BMJ (2012) 1.02
Risk of lung cancer and past use of cannabis in Tunisia. J Thorac Oncol (2006) 1.00
A single weekly bout of exercise may reduce cardiovascular mortality: how little pain for cardiac gain? 'The HUNT study, Norway'. Eur J Cardiovasc Prev Rehabil (2006) 1.00
Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2. Cancer Epidemiol Biomarkers Prev (2010) 0.99
Birth size and subsequent risk for prostate cancer: a prospective population-based study in Norway. Int J Cancer (2005) 0.98
Early sexual maturation, central adiposity and subsequent overweight in late adolescence. a four-year follow-up of 1605 adolescent Norwegian boys and girls: the Young HUNT study. BMC Public Health (2007) 0.98
Endometrial cancer incidence trends in Norway during 1953-2007 and predictions for 2008-2027. Int J Cancer (2010) 0.98
Number and size of nevi are influenced by different sun exposure components: implications for the etiology of cutaneous melanoma (Belgium, Germany, France, Italy). Cancer Causes Control (2003) 0.97
A simple nonexercise model of cardiorespiratory fitness predicts long-term mortality. Med Sci Sports Exerc (2014) 0.97
99mTc-sestamibi brain SPECT after chemoradiotherapy is prognostic of survival in patients with high-grade glioma. J Nucl Med (2004) 0.96
Thyroid function and the risk of coronary heart disease: 12-year follow-up of the HUNT study in Norway. Clin Endocrinol (Oxf) (2012) 0.96
Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002. Int J Cancer (2012) 0.96
Cardiovascular risk factors and systolic and diastolic cardiac function: a tissue Doppler and speckle tracking echocardiographic study. J Am Soc Echocardiogr (2011) 0.96
Perceived pubertal timing, pubertal status and the prevalence of alcohol drinking and cigarette smoking in early and late adolescence: a population based study of 8950 Norwegian boys and girls. Acta Paediatr (2007) 0.95
Peer victimization as reported by children, teachers, and parents in relation to children's health symptoms. BMC Public Health (2011) 0.95
Effect of screening mammography on breast cancer incidence. N Engl J Med (2013) 0.95
Sexual maturation in early adolescence and alcohol drinking and cigarette smoking in late adolescence: a prospective study of 2,129 Norwegian girls and boys. Eur J Pediatr (2005) 0.95
Pregnancy hormones, pre-eclampsia, and implications for breast cancer risk in the offspring. Cancer Epidemiol Biomarkers Prev (2003) 0.94
The association of reproductive factors and breastfeeding with long term survival from breast cancer. Breast Cancer Res Treat (2011) 0.94
Large-scale fine mapping of the HNF1B locus and prostate cancer risk. Hum Mol Genet (2011) 0.94
A nationwide population-based skin cancer screening in Germany: proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009). Cancer Epidemiol (2010) 0.93
Recreational physical activity and cancer risk in subsites of the colon (the Nord-Trøndelag Health Study). Cancer Epidemiol Biomarkers Prev (2008) 0.93
Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction. Am J Epidemiol (2011) 0.93
Baseline prostate-specific antigen level and risk of prostate cancer and prostate-specific mortality: diagnosis is dependent on the intensity of investigation. Cancer Epidemiol Biomarkers Prev (2008) 0.92
Reproductive history and the risk of molecular breast cancer subtypes in a prospective study of Norwegian women. Cancer Causes Control (2014) 0.92
School wellbeing among children in grades 1-10. BMC Public Health (2010) 0.91
An estimate of cancers attributable to occupational exposures in France. J Occup Environ Med (2010) 0.91
Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection. Environ Health Perspect (2011) 0.91
Informativeness of indices of blood pressure, obesity and serum lipids in relation to ischaemic heart disease mortality: the HUNT-II study. Eur J Epidemiol (2011) 0.90